Primary research/trials:

Barrett’s

Accuracy, safety, and tolerability of tissue collection by Cytosponge vs endoscopy for evaluation of eosinophilic esophagitis.
Katzka DA, Geno DM, Ravi A, Smyrk TC, Lao-Sirieix P, Miremadi A, Debiram I, O’Donovan M, Kita H, Kephart GM, Kryzer LA, Camilleri M, Alexander JA, Fitzgerald RC.
Clin Gastroenterol Hepatol. 2015 Jan;13(1):77-83.e2. doi: 10.1016/j.cgh.2014.06.026. Epub 2014 Jul 3.
PMID: 24997328
https://pubmed.ncbi.nlm.nih.gov/24997328/

Advances in the diagnosis and surveillance of Barrett’s esophagus (with videos).
ASGE Technology Committee, Trindade AJ, Navaneethan U, Aslanian HR, Bhutani MS, Krishnan K, Lichtenstein DR, Melson J, Pannala R, Parsi MA, Schulman AR, Sethi A, Trikudanathan G, Watson RR, Maple JT.
Gastrointest Endosc. 2019 Sep;90(3):325-334. doi: 10.1016/j.gie.2019.05.004. Epub 2019 May 18.
PMID: 31113535
https://pubmed.ncbi.nlm.nih.gov/31113535/

Application of a multi-gene next-generation sequencing panel to a non-invasive oesophageal cell-sampling device to diagnose dysplastic Barrett’s oesophagus.
Katz-Summercorn A, Anand S, Ingledew S, Huang Y, Roberts T, Galeano-Dalmau N, O’Donovan M, Liu H, Fitzgerald RC.
J Pathol Clin Res. 2017 Aug 24;3(4):258-267. doi: 10.1002/cjp2.80. eCollection 2017 Oct.
PMID: 29085666 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/29085666/

Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett’s oesophagus with low-grade dysplasia.
di Pietro M, Fitzgerald RC; BSG Barrett’s guidelines working group.
Gut. 2018 Feb;67(2):392-393. doi: 10.1136/gutjnl-2017-314135. Epub 2017 Apr 7.
PMID: 28389530 Free PMC article. No abstract available.
https://pubmed.ncbi.nlm.nih.gov/28389530/

Corrigendum: Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study.
Katzka DA, Smyrk TC, Alexander JA, Geno DM, Beitia RA, Chang AO, Shaheen NJ, Fitzgerald RC, Dellon ES.
Am J Gastroenterol. 2018 Feb;113(2):310. doi: 10.1038/ajg.2017.474. Epub 2017 Dec 19.
PMID: 29257149
https://pubmed.ncbi.nlm.nih.gov/29257149/

Methylation panel is a diagnostic biomarker for Barrett’s oesophagus in endoscopic biopsies and non-endoscopic cytology specimens.
Chettouh H, Mowforth O, Galeano-Dalmau N, Bezawada N, Ross-Innes C, MacRae S, Debiram-Beecham I, O’Donovan M, Fitzgerald RC.
Gut. 2018 Nov;67(11):1942-1949. doi: 10.1136/gutjnl-2017-314026. Epub 2017 Oct 30.
PMID: 29084829 Free PMC article. Clinical Trial.
https://pubmed.ncbi.nlm.nih.gov/29084829/

Barrett’s esophagus: novel strategies for screening and surveillance.
Sanghi V, Thota PN.
Ther Adv Chronic Dis. 2019 Mar 26;10:2040622319837851. doi: 10.1177/2040622319837851. eCollection 2019.
PMID: 30937155 Free PMC article. Review.
https://pubmed.ncbi.nlm.nih.gov/30937155/

Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett’s Esophagus With a Minimally Invasive Cell Sampling Device.
Heberle CR, Omidvari AH, Ali A, Kroep S, Kong CY, Inadomi JM, Rubenstein JH, Tramontano AC, Dowling EC, Hazelton WD, Luebeck EG, Lansdorp-Vogelaar I, Hur C.
Clin Gastroenterol Hepatol. 2017 Sep;15(9):1397-1404.e7. doi: 10.1016/j.cgh.2017.02.017. Epub 2017 Feb 24.
PMID: 28238953 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/28238953/

Oesophageal disease: gastroesophageal reflux disease, Barrett’s oesophagus, achalasia and eosinophilic oesophagitis.
Calvet X.
Gastroenterol Hepatol. 2016 Sep;39 Suppl 1:47-52. doi: 10.1016/S0210-5705(16)30174-1.
PMID: 27888864 English, Spanish.
https://pubmed.ncbi.nlm.nih.gov/27888864/

Barrett’s oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux.
Offman J, Muldrew B, O’Donovan M, Debiram-Beecham I, Pesola F, Kaimi I, Smith SG, Wilson A, Khan Z, Lao-Sirieix P, Aigret B, Walter FM, Rubin G, Morris S, Jackson C, Sasieni P, Fitzgerald RC; BEST3 Trial team.
BMC Cancer. 2018 Aug 3;18(1):784. doi: 10.1186/s12885-018-4664-3.
PMID: 30075763 Free PMC article. Clinical Trial.
https://pubmed.ncbi.nlm.nih.gov/30075763/

A crosssectional analysis of Facebook comments to study public perception of a new diagnostic test called the Cytosponge.
Tan WK, Muldrew B, Khan Z, Fitzgerald RC.
Dis Esophagus. 2019 Jan 1;32(1):10.1093/dote/doy085. doi: 10.1093/dote/doy085.
PMID: 30239646 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/30239646/


EoE, microbiome

Accuracy and Safety of the Cytosponge for Assessing Histologic Activity in Eosinophilic Esophagitis: A Two-Center Study.
Katzka DA, Smyrk TC, Alexander JA, Geno DM, Beitia RA, Chang AO, Shaheen NJ, Fitzgerald RC, Dellon ES.
Am J Gastroenterol. 2017 Oct;112(10):1538-1544. doi: 10.1038/ajg.2017.244. Epub 2017 Aug 15.
PMID: 28809387 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/28809387/

A non-endoscopic device to sample the oesophageal microbiota: a case-control study.
Elliott DRF, Walker AW, O’Donovan M, Parkhill J, Fitzgerald RC.
Lancet Gastroenterol Hepatol. 2017 Jan;2(1):32-42. doi: 10.1016/S2468-1253(16)30086-3. Epub 2016 Nov 12.
PMID: 28404012 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/28404012/

Screening and Prevention of Barrett’s Esophagus.
Pech O.
Visc Med. 2019 Aug;35(4):210-214. doi: 10.1159/000501918. Epub 2019 Jul 25.
PMID: 31602381 Free PMC article. Review.
https://pubmed.ncbi.nlm.nih.gov/31602381/

Risk stratification of Barrett’s oesophagus using a non-endoscopic sampling method coupled with a biomarker panel: a cohort study.
Ross-Innes CS, Chettouh H, Achilleos A, Galeano-Dalmau N, Debiram-Beecham I, MacRae S, Fessas P, Walker E, Varghese S, Evan T, Lao-Sirieix PS, O’Donovan M, Malhotra S, Novelli M, Disep B, Kaye PV, Lovat LB, Haidry R, Griffin M, Ragunath K, Bhandari P, Haycock A, Morris D, Attwood S, Dhar A, Rees C, Rutter MD, Ostler R, Aigret B, Sasieni PD, Fitzgerald RC; BEST2 study group.
Lancet Gastroenterol Hepatol. 2017 Jan;2(1):23-31. doi: 10.1016/S2468-1253(16)30118-2. Epub 2016 Nov 11.
PMID: 28404010
https://pubmed.ncbi.nlm.nih.gov/28404010/


Reviews and Commentaries

Acceptability of the Cytosponge procedure for detecting Barrett’s oesophagus: a qualitative study.
Freeman M, Offman J, Walter FM, Sasieni P, Smith SG.
BMJ Open. 2017 Mar 1;7(3):e013901. doi: 10.1136/bmjopen-2016-013901.
PMID: 28255095 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/28255095/

Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients.
Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators.
Clin Gastroenterol Hepatol. 2019 Mar;17(4):647-656.e1. doi: 10.1016/j.cgh.2018.07.043. Epub 2018 Aug 9.
PMID: 30099104 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/30099104/

Barrett oesophagus: Risk stratification using Cytosponge.
Dickson I.
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):4. doi: 10.1038/nrgastro.2016.203. Epub 2016 Dec 14.
PMID: 27965513 No abstract available.
https://pubmed.ncbi.nlm.nih.gov/27965513/

Safety and efficacy of a minimally invasive cell sampling device (‘Cytosponge’) in the diagnosis of esophageal pathology: a systematic review.
Iqbal U, Siddique O, Ovalle A, Anwar H, Moss SF.
Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1261-1269. doi: 10.1097/MEG.0000000000001210.
PMID: 30044236
https://pubmed.ncbi.nlm.nih.gov/30044236/

A non-endoscopic device to sample the oesophageal microbiota: a case-control study.
Elliott DRF, Walker AW, O’Donovan M, Parkhill J, Fitzgerald RC.
Lancet Gastroenterol Hepatol. 2017 Jan;2(1):32-42. doi: 10.1016/S2468-1253(16)30086-3. Epub 2016 Nov 12.
PMID: 28404012 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/28404012/

New Developments in the Diagnosis and Treatment of Eosinophilic Esophagitis.
Nhu QM, Moawad FJ.
Curr Treat Options Gastroenterol. 2019 Mar;17(1):48-62. doi: 10.1007/s11938-019-00216-7.
PMID: 30707411 Free PMC article. Review.
https://pubmed.ncbi.nlm.nih.gov/30707411/

Detecting Barrett oesophagus using Cytosponge.
Hindson J.
Nat Rev Gastroenterol Hepatol. 2020 Oct;17(10):596. doi: 10.1038/s41575-020-00359-4.
PMID: 32826965 Free PMC article. No abstract available.
https://pubmed.ncbi.nlm.nih.gov/32826965/

Past, present and future of Barrett’s oesophagus.
Tan WK, di Pietro M, Fitzgerald RC.
Eur J Surg Oncol. 2017 Jul;43(7):1148-1160. doi: 10.1016/j.ejso.2017.02.004. Epub 2017 Feb 16.
PMID: 28256346 Free PMC article. Review.
https://pubmed.ncbi.nlm.nih.gov/28256346/

Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett’s esophagus: a multi-center case-control study.
Ross-Innes CS, Debiram-Beecham I, O’Donovan M, Walker E, Varghese S, Lao-Sirieix P, Lovat L, Griffin M, Ragunath K, Haidry R, Sami SS, Kaye P, Novelli M, Disep B, Ostler R, Aigret B, North BV, Bhandari P, Haycock A, Morris D, Attwood S, Dhar A, Rees C, Rutter MD, Sasieni PD, Fitzgerald RC; BEST2 Study Group.
PLoS Med. 2015 Jan 29;12(1):e1001780. doi: 10.1371/journal.pmed.1001780. eCollection 2015 Jan.
PMID: 25634542 Free PMC article.
https://pubmed.ncbi.nlm.nih.gov/25634542/

Alternatives to Traditional Per-Oral Endoscopy for Screening.
Offman J, Fitzgerald RC.
Gastrointest Endosc Clin N Am. 2017 Jul;27(3):379-396. doi: 10.1016/j.giec.2017.02.002. Epub 2017 Apr 4.
PMID: 28577763 Free PMC article. Review.
https://pubmed.ncbi.nlm.nih.gov/28577763/

Early detection and therapeutics.
Januszewicz W, Fitzgerald RC.
Mol Oncol. 2019 Mar;13(3):599-613. doi: 10.1002/1878-0261.12458. Epub 2019 Feb 20.
PMID: 30677217 Free PMC article. Review.
https://pubmed.ncbi.nlm.nih.gov/30677217/

Screening for Barrett’s Esophagus: Are New High-Volume Methods Feasible?
O’Donovan M, Fitzgerald RC.
Dig Dis Sci. 2018 Aug;63(8):2105-2114. doi: 10.1007/s10620-018-5192-3.
PMID: 29995243 Free PMC article. Review.
https://pubmed.ncbi.nlm.nih.gov/29995243/

[Barrett-Screening: Rational, current concepts and perspectives].
Weismüller J, Thieme R, Hoffmeister A, Weismüller T, Gockel I.
Z Gastroenterol. 2019 Mar;57(3):317-326. doi: 10.1055/a-0832-2647. Epub 2019 Mar 12.
PMID: 30861556 German.
https://pubmed.ncbi.nlm.nih.gov/30861556/

Close Bitnami banner
Bitnami